Complement C5 controls liver lipid profile, promotes liver homeostasis and inflammation in C57BL/6 genetic background

Bavia, 2013, The influence of genetic background of C57BL/6 and A/J mice on the development of acute inflammatory response induced by alcohol, Rev. Soc. Bras. Ciên. Anim. Lab., 2, 124 Bavia, 2014, Basal physiological parameters of two congenic mice strains: C5 deficient C57BL/6 and C5 sufficient A/J, Immunol. Lett., 159, 47, 10.1016/j.imlet.2014.02.010 Bavia, 2015, C57BL/6 and A/J mice have different inflammatory response and liver lipid profile in experimental alcoholic liver disease, Mediators Inflamm., 1, 10.1155/2015/491641 Boone, 2005, Selection and interpretation of clinical pathology indicators of hepatic injury in preclinical studies, Vet. Clin. Pathol., 34, 182, 10.1111/j.1939-165X.2005.tb00041.x Bosmann, 2012, Evidence for anti-inflammatory effects of C5a on the innate IL-17A/IL-23 axis, FASEB J., 26, 1640, 10.1096/fj.11-199216 Bykov, 2007, Hepatic gene expression and lipid parameters in complement C3(-/-) mice that do not develop ethanol-induced steatosis, J. Hepatol., 46, 907, 10.1016/j.jhep.2006.11.020 Bykov, 2006, Complement C3 contributes to ethanol-induced liver steatosis in mice, Ann. Med., 38, 280, 10.1080/07853890600664608 Bykov, 2007, Effect of chronic ethanol consumption on the expression of complement components and acute-phase proteins in liver, Clin. Immunol., 124, 213, 10.1016/j.clim.2007.05.008 Bykov, 2004, Oral chronic ethanol administration to rodents by agar gel diet, Alcohol Alcohol, 39, 499, 10.1093/alcalc/agh103 Bykov, 2004, Protective function of complement against alcohol-induced rat liver damage, Int. Immunopharmacol., 4, 1445, 10.1016/j.intimp.2004.06.008 Fisette, 2013, C5L2 receptor disruption enhances the development of diet-induced insulin resistance in mice, Immunobiology, 218, 127, 10.1016/j.imbio.2012.04.001 Hill, 2002, A role for interleukin-10 in alcohol-induced liver sensitization to bacterial lipopolysaccharide, Alcohol Clin. Exp. Res., 26, 74, 10.1111/j.1530-0277.2002.tb02434.x Hines, 2004, Recent advances in alcoholic liver disease III. Role of the innate immune response in alcoholic hepatitis, Am. J. Physiol. Gastrointest Liver Physiol., 287, G310, 10.1152/ajpgi.00094.2004 Hu, 2015, Sterol metabolism controls T(H) 17 differentiation by generating endogenous RORγ agonists, Nat. Chem. Biol., 11, 141, 10.1038/nchembio.1714 Iimuro, 1997, Antibodies to tumor necrosis factor alfa attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat, Hepatology, 26, 1530, 10.1002/hep.510260621 Järveläinen, 2002, Activation of complement components and reduced regulator expression in alcohol-induced liver injury in the rat, Clin. Immunol., 105, 57, 10.1006/clim.2002.5267 Karkampouna, 2012, TGFβ signaling in liver regeneration, Curr. Pharm. Des., 18, 4103, 10.2174/138161212802430521 Kawaratani, 2013, The effect of inflammatory cytokines in alcoholic liver disease, Mediators Inflamm., 2013, 495156, 10.1155/2013/495156 Kleiner, 2005, Design and validation of a histological scoring system for nonalcoholic fatty liver disease, Hepatology, 41, 1313, 10.1002/hep.20701 Kondo, 2006, Differential regulation of intestinal lipid metabolism-related genes in obesity-resistant A/J vs: obesity-prone C57BL/6J mice, Am. J. Physiol. Endocrinol. Metab., 291, E1092, 10.1152/ajpendo.00583.2005 Korn, 2009, IL-17 and Th17 cells, Annu. Rev. Immunol., 27, 485, 10.1146/annurev.immunol.021908.132710 Laskin, 2011, Macrophages and tissue injury: agents of defense or destruction, Annu. Rev. Pharmacol. Toxicol., 51, 267, 10.1146/annurev.pharmtox.010909.105812 Lemmers, 2009, The interleukin-17 pathway is involved in human alcoholic liver disease, Hepatology, 49, 646, 10.1002/hep.22680 Lieber, 2004, Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis, Alcohol, 34, 9, 10.1016/j.alcohol.2004.07.008 Lieber, 1982, The feeding of alcohol in liquid diets: two decades of applications and 1982 update, Alcohol Clin. Exp. Res., 6, 523, 10.1111/j.1530-0277.1982.tb05017.x MacLaren, 2008, Adipokines and the immune system: an adipocentric view, Adv. Exp. Med. Biol., 632, 1, 10.1007/978-0-387-78952-1_1 Mandal, 2010, Anti-inflammatory pathways and alcoholic liver disease: role of an adiponectin/interleukin-10/heme oxygenase-1 pathway, World J. Gastroenterol., 16, 1330, 10.3748/wjg.v16.i11.1330 Mandrekar, 2014, Immunity and inflammatory signaling in alcoholic liver disease, Hepatol. Int., 8, 439, 10.1007/s12072-014-9518-8 Martinon, 2009, The inflammasomes: guardians of the body, Annu. Rev. Immunol., 27, 229, 10.1146/annurev.immunol.021908.132715 McClain, 1998, Tumor necrosis factor and alcoholic liver disease, Alcohol Clin. Exp. Res., 22, 248S, 10.1111/j.1530-0277.1998.tb04011.x Nagata, 2007, Common pathogenic mechanism in development progression of liver injury caused by non-alcoholic or alcoholic steatohepatitis, J. Toxicol. Sci., 32, 453, 10.2131/jts.32.453 O'Shea, 2008, Cytokine signaling modules in inflammatory responses, Immunity, 28, 477, 10.1016/j.immuni.2008.03.002 Petrasek, 2012, IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice, J. Clin. Invest., 122, 3476, 10.1172/JCI60777 Poursharifi, 2014, C5aR and C5L2 act in concert to balance immunometabolism in adipose tissue, Mol. Cell Endocrinol., 382, 325, 10.1016/j.mce.2013.10.019 Pritchard, 2007, Differential contributions of C3, C5, and decay-accelerating factor to ethanol-induced fatty liver in mice, Gastroenterology, 132, 1117, 10.1053/j.gastro.2007.01.053 Roychowdhury, 2009, An early complement-dependent and TLR-4-independent phase in the pathogenesis of ethanol-induced liver injury in mice, Hepatology, 49, 1326, 10.1002/hep.22776 Russell, 2003, The enzymes, regulation, and genetics of bile acid synthesis, Annu. Rev. Biochem., 72, 137, 10.1146/annurev.biochem.72.121801.161712 Sanjabi, 2009, Anti-inflammatory and pro-inflammatory roles of TGF-beta, IL-10, and IL-22 in immunity and autoimmunity, Curr. Opin. Pharmacol., 9, 447, 10.1016/j.coph.2009.04.008 Shi, 2013, Anti-IL-17 antibody improves hepatic steatosis by suppressing interleukin-17-related fatty acid synthesis and metabolism, Clin. Dev. Immunol., 2013, 253046, 10.1155/2013/253046 Strey, 2003, The proinflammatory mediators C3a and C5a are essential for liver regeneration, J. Exp. Med., 198, 913, 10.1084/jem.20030374 Szabo, 2012, Innate immunity and alcoholic liver disease, Dig. Dis., 30, 55, 10.1159/000341126 WHO, 2014, Global Status Report on Alcohol and Health Wetsel, 1990, Deficiency of the murine fifth complement component (C5): a 2-base pair gene deletion in a 5'-exon, J. Biol. Chem., 265, 2435, 10.1016/S0021-9258(19)39817-5 Yin, 1999, Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice, Gastroenterology, 117, 942, 10.1016/S0016-5085(99)70354-9 Yoneyama, 2008, Voluntary ethanol consumption in 22 inbred mouse strains, Alcohol, 42, 149, 10.1016/j.alcohol.2007.12.006